Root Financial Partners »

Lineage Cell Therapeutics In shares owned by Root Financial Partners

Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Root Financial Partners from 13F filings

Historical chart of Root Financial Partners investment in Lineage Cell Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including Lineage Cell Therapeutics In held by Root Financial Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lineage Cell Therapeutics In by Root Financial Partners

Quarter filed Position value Share count Share price at filing
2026-09-30 $1 1 1.00

More positions owned by Root Financial Partners

Dimensional U.s. Equity Market Etf Etf (DFUS)
Dimensional Us Large Cap Value Etf Etf (DFLV)
Dimensional International Core Equity Market Etf Etf (DFAI)
U.s. Small Cap Portfolio Etf Etf (DFAS)
Dimensional Short-duration Fixed Income Etf Etf (DFSD)
Dimensional Core Fixed Income Etf Etf (DFCF)
Dimensional Emerging Core Equity Market Etf Etf (DFAE)
Dimensional Ultrashort Fixed Income Etf Etf (DUSB)
U.s. High Relative Profitability Portfolio: Etf Class Shares Etf (DUHP)
Dimensional International Value Etf Etf (DFIV)
Vanguard Morningstar Growth Etf Etf (VUG)
Dimensional International Small Cap Etf Etf (DFIS)
Dfa Real Estate Securities Portfolio: Etf Class Shares Etf (DFAR)
Nvidia Corporation Stock (NVDA)
Dimensional Emerging Markets Value Etf Etf (DFEV)

View all positions for Root Financial Partners

Top funds holding Lineage Cell Therapeutics In

Broadwood Capital
BlackRock
Vanguard Capital Management
Defender Capital
Geode Capital Management
Raffles Associates
Fifth Third Bancorp
Millennium Management
State Street Corporation
Vanguard Fiduciary Trust
Northern Trust
Renaissance Technologies
Marshall Wace
Vanguard Portfolio Management
UBS Group

View all funds holding Lineage Cell Therapeutics In